A detailed history of Headlands Technologies LLC transactions in Axonics, Inc. stock. As of the latest transaction made, Headlands Technologies LLC holds 4,891 shares of AXNX stock, worth $347,163. This represents 0.04% of its overall portfolio holdings.

Number of Shares
4,891
Previous 2,928 67.04%
Holding current value
$347,163
Previous $196,000 73.47%
% of portfolio
0.04%
Previous 0.02%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$67.3 - $69.67 $132,109 - $136,762
1,963 Added 67.04%
4,891 $340,000
Q2 2024

Aug 07, 2024

BUY
$66.47 - $69.65 $120,377 - $126,136
1,811 Added 162.13%
2,928 $196,000
Q1 2024

May 07, 2024

BUY
$56.67 - $69.36 $15,017 - $18,380
265 Added 31.1%
1,117 $77,000
Q4 2023

Feb 02, 2024

BUY
$49.38 - $63.75 $42,071 - $54,315
852 New
852 $53,000
Q2 2023

Aug 03, 2023

BUY
$47.99 - $60.21 $209,524 - $262,876
4,366 New
4,366 $220,000

Others Institutions Holding AXNX

About Axonics, Inc.


  • Ticker AXNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 49,123,600
  • Market Cap $3.49B
  • Description
  • Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...
More about AXNX
Track This Portfolio

Track Headlands Technologies LLC Portfolio

Follow Headlands Technologies LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Headlands Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Headlands Technologies LLC with notifications on news.